Clinical Trial Update: Efficacy of Favipiravir Against Ebola (JIKI) [Phase 2]

View source ↗

Summary

Phase 2 trial (JIKI) evaluating Favipiravir for Ebola virus disease has completed; the update summarizes the efficacy findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• Favipiravir (favipiravir)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Ebola Virus Disease | Phase 2 | Status: COMPLETED